Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 September 2021 | Story Jóhann Thormählen | Photo Charl Devenish
The University of the Free State celebrated the achievements of the Paralympic athlete, Louzanne Coetzee. She won silver and bronze medals at the Paralympic Games in Tokyo.

It is great to be back with her University of the Free State (UFS) family, and Louzanne Coetzee would not have been able to reach her dreams without her Kovsie support.

The Paralympic star thanked the UFS for the role it played in her career and said it was a privilege to represent the UFS and South Africa.

She returned from the Paralympic Games in Tokyo with silver (1 500 m; T11) and bronze (marathon; T12) medals and was welcomed back at a special UFS celebration on 13 September 2021.

The 28-year-old, her guides – Estean Badenhorst and Claus Kempen – and a small group of UFS dignitaries celebrated her achievements.

The Residence Head of Akasia Residence at the UFS not only brought home two medals, but also set a new 1 500 m African record (T11; 4:40.96) and a new world marathon record (T11; 3:11:13) in her class.

Support from home

Coetzee is a UFS alumna who started running while being a Kovsie student.

“Thank you so much for the welcome back,” she said.

“It is great to come back home to my UFS family. Especially after three weeks in another country.”

She said the support messages from the likes of Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, meant a lot while she was in Tokyo.

“I, Claus, and Estean would not have been able to do this without the support of the UFS and Oom DB (Prinsloo; Director of KovsieSport).”

Representing the UFS and the continent

She made special mention of Badenhorst and Kempen, who also run for the Kovsie Athletics Club. “I really feel we function well as a team, and I think the results have been fruitful.”

Prof Petersen praised and thanked them, also for representing the UFS, South Africa, and the continent in such a superb manner.

It is great to come back home to my UFS family. Especially after three weeks in another country. – Louzanne Coetzee

 

“You really made us proud as the University of the Free State family, and I know that you will continue with great performances in the future,” he said.

Prinsloo said KovsieSport is immensely proud of the trio and for being UFS ambassadors.

“Thank you very much. We are looking forward to the next couple of years.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept